list of glp 1 agonists approved and pending GLP-1 medications GLP-1 receptor agonists | How

These medications have undergone extensive clinical trials to evaluate their efficacy and safety in managing type 2 diabetes and, more recently, their potential for weight loss

GLP-1 Safety: Known Risks and Rare Complications While GLP-1 medications are clinically proven to be safe, they carry specific risks that require professional oversight

In 2019, the FDA approves semaglutide (Rybelsus), the first oral GLP-1 analog treatment for adults with type 2 diabetes

The review also discusses emerging data in peripheral artery disease (e.g., STRIDE trial)

4,7 In this regard, this addition ensures a more comprehensive discussion aligned with current expert consensus on risk mitigation strategies

Mechanism: GLP-1 receptor agonist